Published in Occup Environ Med on January 01, 1997
Pulmonary epithelial integrity in children: relationship to ambient ozone exposure and swimming pool attendance. Environ Health Perspect (2004) 1.87
Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant (2011) 1.10
Daily variation in fine and ultrafine particulate air pollution and urinary concentrations of lung Clara cell protein CC16. Occup Environ Med (2004) 0.90
Association of Children's Urinary CC16 Levels with Arsenic Concentrations in Multiple Environmental Media. Int J Environ Res Public Health (2016) 0.88
Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates. Eur J Pediatr (2008) 0.87
The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol (2005) 0.85
Serum biomarkers in interstitial lung diseases. Respir Res (2005) 0.85
Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia? Crit Care (2011) 0.84
Regulation of uteroglobin/Clara cell protein expression after acute lung exposure to an organophosphoreted insecticide. Histochem Cell Biol (2003) 0.83
Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats. Lung (2004) 0.78
Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD). Expert Opin Ther Targets (2016) 0.76
Pneumoproteins in sewage workers exposed to sewage dust. Int Arch Occup Environ Health (2012) 0.76
Diurnal physiological and immunological responses to a 10-km run in highly trained athletes in an environmentally controlled condition of 6 °C. Eur J Appl Physiol (2016) 0.75
Pulmonary function in firefighters: acute changes in ventilatory capacity and their correlates. Br J Ind Med (1979) 1.61
Continuous-flow system for automation of latex immunoassay by particle counting. Clin Chem (1983) 1.52
Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J (1992) 1.49
Acute and chronic effects of fire fighting on pulmonary function. Chest (1980) 1.08
Decrease of serum Clara cell protein in smokers. Lancet (1992) 0.99
The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta (1993) 0.97
Early decrease of serum Clara cell protein in silica-exposed workers. Eur Respir J (1994) 0.96
Alteration in surface structure of Clara cells and pulmonary cytochrome P-450b level in rats exposed to ozone. Toxicology (1992) 0.86
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med (2003) 2.16
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2001) 1.99
Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia. Haemophilia (2007) 1.46
Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci (2000) 1.45
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study. Respir Med (2009) 1.32
Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J Biol Chem (1999) 1.28
Food contamination by PCBs and dioxins. Nature (1999) 1.26
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J (2002) 1.18
Proteinuria: changes and mechanisms in toxic nephropathies. Crit Rev Toxicol (1991) 1.17
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2002) 1.16
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2000) 1.08
Lung epithelial damage at low concentrations of ambient ozone. Lancet (1999) 1.06
Epidemiological application of early markers of nephrotoxicity. Toxicol Lett (1989) 1.05
The European Principles of Haemophilia Care: a pilot investigation of adherence to the principles in Europe. Haemophilia (2012) 1.03
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia (2007) 1.02
Association between plasma CC16 levels, the A38G polymorphism, and asthma. Am J Respir Crit Care Med (2000) 0.98
Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis (2000) 0.96
The role of physiotherapy after total knee arthroplasty in patients with haemophilia. Haemophilia (2008) 0.95
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1999) 0.94
BARCOS, an automation and remote control system for atmospheric observations with a Bruker interferometer. Rev Sci Instrum (2007) 0.93
Clearance of Clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med (1998) 0.92
Exposure to diesel exhaust nanoparticles does not induce blood hypercoagulability in an at-risk population. J Thromb Haemost (2005) 0.91
The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Haemophilia (2011) 0.90
Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival. Crit Care Med (2000) 0.90
Mitochondrial hydrogen peroxide generation by NADH-oxidase activity following regional myocardial ischemia in the dog. J Mol Cell Cardiol (1989) 0.90
Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin Chim Acta (1992) 0.90
Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Electrophoresis (1999) 0.90
Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect (2000) 0.89
Cadmium and health: the Belgian experience. IARC Sci Publ (1992) 0.89
TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man. Lab Invest (2000) 0.89
Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour. Br J Ind Med (1990) 0.88
Sporadic case of listeriosis associated with the consumption of a Listeria monocytogenes-contaminated 'Camembert' cheese. J Infect (1997) 0.88
Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Respir J (1998) 0.87
European curriculum for thrombosis and haemostasis. Haemophilia (2009) 0.86
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A. Haemophilia (2007) 0.84
Recommendations for assessment, monitoring and follow-up of patients with haemophilia. Haemophilia (2011) 0.84
Biomonitoring of early effects on the kidney or the lung. Sci Total Environ (1997) 0.84
Identification of de novo deletion in the factor VIII gene by MLPA technique in two girls with isolated factor VIII deficiency. Haemophilia (2009) 0.82
The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group. Haemophilia (2003) 0.82
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer. Eur J Cancer (2003) 0.82
Interplay between platelet-derived 5-hydroxytryptamine and arachidonic acid metabolites limits the thrombolytic efficacy of streptokinase against canine platelet-rich coronary thrombosis. J Cardiovasc Pharmacol (1993) 0.82
Effects of ambient ozone on the procoagulant status and systemic inflammatory response. J Thromb Haemost (2005) 0.82
Diffuse intravascular coagulation complicating thrombosis of a popliteal aneurysm: a case report. Angiology (1986) 0.81
Continuous infusion in haemophilia: current practice in Europe. Haemophilia (2012) 0.81
Guidelines for the use of fresh frozen plasma. Acta Clin Belg (2009) 0.81
Effects of R 56,865, a preventer of cellular calcium overload, on left ventricular diastolic properties during pacing-induced ischemia in dogs. J Cardiovasc Pharmacol (1991) 0.81
Serum Clara cell protein (CC16) in healthy young smokers. Biomarkers (2000) 0.80
Body weight and fat mass index as strong predictors of factor VIII in vivo recovery in adults with hemophilia A. J Thromb Haemost (2011) 0.80
Physical and mental quality of life in adult patients with haemophilia in Belgium: the impact of financial issues. Haemophilia (2013) 0.80
Priming solutions for cardiopulmonary bypass: comparison of three colloids. J Cardiothorac Vasc Anesth (1991) 0.80
Challenges and controversies in haemophilia care in adulthood. Haemophilia (2009) 0.80
Impact of multiple joint impairments on the energetics and mechanics of walking in patients with haemophilia. Haemophilia (2012) 0.79
Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study). Int J Clin Pract (2011) 0.79
Functional impact of custom-made foot orthoses in patients with haemophilic ankle arthropathy. Haemophilia (2011) 0.79
Correlation of HSP110 expression with all-trans retinoic acid-induced apoptosis. J Craniofac Genet Dev Biol (2001) 0.79
Abstracts of the 6th FECS Conference 1998 Lectures. Environ Sci Pollut Res Int (1998) 0.79
Natural progression of blood-induced joint damage in patients with haemophilia: clinical relevance and reproducibility of three-dimensional gait analysis. Haemophilia (2010) 0.78
The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice. J Thromb Haemost (2015) 0.78
Potentiation of diabetic glomerulopathy in uninephrectomized rats subchronically exposed to cadmium. Toxicol Lett (1991) 0.78
FXI concentrate use and risk of thrombosis. Haemophilia (2014) 0.78
Body structure versus body function in haemophilia: the case of haemophilic ankle arthropathy. Haemophilia (2011) 0.78
Survival and neurological outcome of the Mongolian gerbil with or without bilateral carotid ligation after treatment with ether, thiopental or etomidate. Arch Int Pharmacodyn Ther (1983) 0.78
Epidemiology of inhibitor formation with recombinant factor VIII replacement therapy. Haemophilia (2006) 0.77
The renal handling of protein 1 (Clara cell protein): effect of age, sex and renal dysfunction. Contrib Nephrol (1993) 0.77
Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation. Am J Kidney Dis (1999) 0.77
Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: a sub-analysis of the Belgian PREVIEW study. J Hum Hypertens (2010) 0.77
Computational and molecular approaches for predicting unreported causal missense mutations in Belgian patients with haemophilia A. Haemophilia (2011) 0.77
Subclinical deep venous thrombosis observed in 10% of hemophilic patients undergoing major orthopedic surgery. J Thromb Haemost (2010) 0.77
Pharmacokinetics, phenotype and product choice in haemophilia B: how to strike a balance? Haemophilia (2014) 0.76
A 1.7-megabase sequence-ready cosmid contig covering the TSC1 candidate region in 9q34. Genomics (1997) 0.76
Cancer detection and management in patients with haemophilia: a retrospective European multicentre study. Haemophilia (2013) 0.76
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency. Haemophilia (2002) 0.76
Assessment of the causality of the cadmium--protein relationships in the urine of the general population with reference to the Cadmibel study. IARC Sci Publ (1992) 0.76
Stunned myocardium has increased mitochondrial NADH oxidase and ATPase activities. Cardioscience (1991) 0.76
Assessing options for treating haemophilia with inhibitors. Haemophilia (2015) 0.76
Cosmid contigs from the tuberous sclerosis candidate region on chromosome 9q34. Eur J Hum Genet (1995) 0.75
More on gastric antral vascular ectasia (watermelon stomach) in uremic patients. Perit Dial Int (1997) 0.75
Ultrastructural damage and Ca2(+)-shifts in the canine myocardium subjected to regional incomplete ischemia. Basic Res Cardiol (1990) 0.75
Prevalence of clotting factor deficiencies in a large population with von Willebrand disease. Thromb Haemost (2000) 0.75
Protective effects of etomidate in hypoxic-ischemic brain damage in the rat. A morphologic assessment. Exp Neurol (1982) 0.75
Novel products for haemostasis. Haemophilia (2014) 0.75
Reassessment of the correlation between the von Willebrand Factor activity, the PFA-100, and the bleeding time in patients with von Willebrand disease. Thromb Haemost (2001) 0.75
NITROGEN USE EFFICIENCY IN NATURAL POPULATIONS OF ARABIDOPSIS THALIANA. Commun Agric Appl Biol Sci (2015) 0.75
[Rivaroxaban: Xarelto--recommendations for pharmacists]. J Pharm Belg (2013) 0.75
ROOT MORPHOLOGY OF ARABIDOPSIS THALIANA IN RESPONSE TO MAGNESIUM SUPPLY. Commun Agric Appl Biol Sci (2015) 0.75
Algorithm analysis of lectin glycohistochemistry and Feulgen cytometry for a new classification of nasal polyposis. Ann Otol Rhinol Laryngol (1997) 0.75
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens. Anticancer Drugs (1999) 0.75
[New method of detection of stipple cells. Confirmation, thanks to this method, of the identity of reticulocytes with stipple cells and diffuse polychromatic stipple cells]. Arch Mal Prof (1968) 0.75
[Coagulation factors and hemostatic agents]. J Pharm Belg (2004) 0.75
[Current advances in hemostatic and antithrombotic agents]. J Pharm Belg (2004) 0.75
Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study). Nutr Metab Cardiovasc Dis (2011) 0.75
Global incomplete ischemia in dogs assessed by quantitative EEG analysis. Effects of hypnotics and flunarizine. Prog Brain Res (1984) 0.75
[Differential diagnosis of anal eczema]. Hautarzt (2015) 0.75
Inadvertent anticoagulation of a haemophiliac child with routine line flushing. Haemophilia (2006) 0.75
Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease. Br J Haematol (2004) 0.75
Kinetics of the reaction of calcium sulfite and calcium carbonate with sulfur dioxide and oxygen in the presence of calcium chloride. Environ Sci Technol (1981) 0.75